Cargando…

Overexpression and Role of HHLA2, a Novel Immune Checkpoint, in Colorectal Cancer

The study aimed to investigate correlations between HHLA2 levels and parameters, including microsatellite instability (MSI) status, CD8+ cells, and histopathological features: budding, tumor-infiltrating lymphocytes (TILs), TNM scale, grading, cytokines, chemokines, and cell signaling moleculesin co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kula, Agnieszka, Dawidowicz, Miriam, Mielcarska, Sylwia, Kiczmer, Paweł, Skiba, Hanna, Krygier, Małgorzata, Chrabańska, Magdalena, Piecuch, Jerzy, Szrot, Monika, Robotycka, Julia, Ochman, Błażej, Strzałkowska, Bogumiła, Czuba, Zenon, Świętochowska, Elżbieta, Waniczek, Dariusz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057377/ https://www.ncbi.nlm.nih.gov/pubmed/36982953 http://dx.doi.org/10.3390/ijms24065876

Ejemplares similares

B7H4 Expression Is More Frequent in MSS Status Colorectal Cancer and Is Negatively Associated with Tumour Infiltrating Lymphocytes
por: Dawidowicz, Miriam, et al.
Publicado: (2023)

B7H3 Role in Reshaping Immunosuppressive Landscape in MSI and MSS Colorectal Cancer Tumours
por: Mielcarska, Sylwia, et al.
Publicado: (2023)

Do Elevated YKL-40 Levels Drive the Immunosuppressive Tumor Microenvironment in Colorectal Cancer? Assessment of the Association of the Expression of YKL-40, MMP-8, IL17A, and PD-L1 with Coexisting Type 2 Diabetes, Obesity, and Active Smoking
por: Ochman, Błażej, et al.
Publicado: (2023)

Periostin in Angiogenesis and Inflammation in CRC—A Preliminary Observational Study
por: Kula, Agnieszka, et al.
Publicado: (2022)

The Concentration of CMKLR1 Expression on Clinicopathological Parameters of Colorectal Cancer: A Preliminary Study
por: Kiczmer, Paweł, et al.
Publicado: (2021)

Assessment of the RANTES Level Correlation and Selected Inflammatory and Pro-Angiogenic Molecules Evaluation of Their Influence on CRC Clinical Features: A Preliminary Observational Study
por: Mielcarska, Sylwia, et al.
Publicado: (2022)

Salivary Concentrations of Chemerin, α-Defensin 1, and TNF-α as Potential Biomarkers in the Early Diagnosis of Colorectal Cancer
por: Waniczek, Dariusz, et al.
Publicado: (2022)

PiRNA Obtained through Liquid Biopsy as a Possible Cancer Biomarker
por: Limanówka, Piotr, et al.
Publicado: (2023)

Perioperative high dose rate (HDR) brachytherapy in unresectable locally advanced pancreatic tumors
por: Waniczek, Dariusz, et al.
Publicado: (2011)

Effective treatment of solitary rectal ulcer syndrome using argon plasma coagulation
por: Waniczek, Dariusz, et al.
Publicado: (2014)

Transcutaneous intravascular transposition of a permanent dialysis catheter
por: Piecuch, Jerzy, et al.
Publicado: (2014)

Adjunct Methods of the Standard Diabetic Foot Ulceration Therapy
por: Waniczek, Dariusz, et al.
Publicado: (2013)

KIR3DL3-HHLA2 and TMIGD2-HHLA2 pathways: The dual role of HHLA2 in immune responses and its potential therapeutic approach for cancer immunotherapy
por: Li, Yang, et al.
Publicado: (2022)

Effect of Weight Loss Surgery on Biomarkers of Angiogenesis in Obese Patients
por: Wiewiora, Maciej, et al.
Publicado: (2020)

Lung Cancer Cytology: Can Any of the Cytological Methods Replace Histopathology?
por: Chrabańska, Magdalena, et al.
Publicado: (2020)

Immunohistochemical Expression of CD44, MMP-2, MMP-9, and Ki-67 as the Prognostic Markers in Non-Clear Cell Renal Cell Carcinomas—A Prospective Cohort Study
por: Chrabańska, Magdalena, et al.
Publicado: (2022)

Does the Immunohistochemical Expression of CD44, MMP-2, and MMP-9 in Association with the Histopathological Subtype of Renal Cell Carcinoma Affect the Survival of Patients with Renal Cancer?
por: Chrabańska, Magdalena, et al.
Publicado: (2023)

Incidence of Concomitant Neoplastic Diseases, Tumor Characteristics, and the Survival of Patients with Lung Adenocarcinoma or Squamous Cell Lung Carcinoma in Tobacco Smokers and Non-Smokers—10-Year Retrospective Single-Centre Cohort Study
por: Ochman, Błażej, et al.
Publicado: (2023)

Regulation of HHLA2 expression in kidney cancer and myeloid cells
por: Shigemura, Tomonari, et al.
Publicado: (2023)

Clinical Significance of the HHLA2 Protein in Hepatocellular Carcinoma and the Tumor Microenvironment
por: Luo, Min, et al.
Publicado: (2021)

HHLA2 Expression is Associated with Poor Survival in Patients with Hepatocellular Carcinoma
por: Xu, Yituo, et al.
Publicado: (2021)

Prognostic Significance of Potential Immune Checkpoint Member HHLA2 in Human Tumors: A Comprehensive Analysis
por: Wang, Ben, et al.
Publicado: (2019)

Clinical Significance of the HHLA2 Protein in Hepatocellular Carcinoma and the Tumor Microenvironment [Corrigendum]
Publicado: (2021)

HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1
por: Jing, Chu-Yu, et al.
Publicado: (2019)

HHLA2 is a novel prognostic predictor and potential therapeutic target in malignant glioma
por: Qi, Yangzhi, et al.
Publicado: (2019)

HHLA2 predicts better survival and exhibits inhibited proliferation in epithelial ovarian cancer
por: Xu, Guocai, et al.
Publicado: (2021)

HHLA2 is a novel prognostic predictor and potential therapeutic target in malignant glioma
por: Qi, Yangzhi, et al.
Publicado: (2022)

Circulating concentration of markers of angiogenic activity in patients with sarcoidosis and idiopathic pulmonary fibrosis
por: Ziora, Dariusz, et al.
Publicado: (2015)

Direct MRI Fistulography with Hydrogen Peroxide in Patients with Recurrent Perianal Fistulas: A New Proposal of Extended Diagnostics
por: Waniczek, Dariusz, et al.
Publicado: (2015)

Relationship between the Ubiquitin–Proteasome System and Autophagy in Colorectal Cancer Tissue
por: Bednarczyk, Martyna, et al.
Publicado: (2023)

Over-Expression and Prognostic Significance of HHLA2, a New Immune Checkpoint Molecule, in Human Clear Cell Renal Cell Carcinoma
por: Zhang, Zhen, et al.
Publicado: (2020)

HHLA2 is expressed in pancreatic and ampullary cancers and increased expression is associated with better post-surgical prognosis
por: Boor, Patrick P. C., et al.
Publicado: (2020)

Prognostic value of HHLA2 expression in solid tumors: A meta-analysis based on the Chinese population
por: Zhang, Chuanmeng, et al.
Publicado: (2021)

HHLA2 Used as a Potential Prognostic and Immunological Biomarker and Correlated with Tumor Microenvironment in Pan-Cancer
por: Yang, Zeng, et al.
Publicado: (2022)

Comprehensive Analysis of HHLA2 as a Prognostic Biomarker and Its Association With Immune Infiltrates in Hepatocellular Carcinoma
por: Ding, Lin, et al.
Publicado: (2022)

Increased co-expression of stromal HHLA2 and fibroblast activation protein in upper tract urothelial carcinoma
por: Nishihara, Daisaku, et al.
Publicado: (2023)

Inhibition of Inflammatory Mediators by Neobavaisoflavone in Activated RAW264.7 Macrophages
por: Szliszka, Ewelina, et al.
Publicado: (2011)

Th17 cytokines and factors modulating their activity in patients with pernicious anemia
por: Kajdaniuk, Dariusz, et al.
Publicado: (2023)

The combination of novel immune checkpoints HHLA2 and ICOSLG: A new system to predict survival and immune features in esophageal squamous cell carcinoma
por: Zhang, Chaoqi, et al.
Publicado: (2020)

Immunosuppression by Inflammation-Stimulated Amplification of Myeloid-Derived Suppressor Cells and Changes in Expression of Immune Checkpoint HHLA2 in Chronic Obstructive Pulmonary Disease
por: Xu, Lijuan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_866tuniqjqeh69kcepmuj0p2pb